Vidal Primiterio
Medical · Lawrence, MANPI 1861472987
Payments from drug & device makers
Across 1,049 payments — averaging $21.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$4K
- AbbVie$3K
- Pfizer$2K
- Amgen$1K
- Novo Nordisk$1K
- Bayer$1K
- plus $11K from 42 others
What the payments were for
- Food & beverage$22,03699%
- Education$1891%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$22,225 in reported general payments places this provider in the 95th percentile of 421 medical providers in Massachusetts.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JanuviaSitagliptin Phosphate | 275 | $322,009 |
| JardianceEmpagliflozin | 180 | $245,901 |
| LinzessLinaclotide | 160 | $176,276 |
| FarxigaDapagliflozin Propanediol | 115 | $160,358 |
| TrulicityDulaglutide | 128 | $157,132 |
| EliquisApixaban | 104 | $116,081 |
| XareltoRivaroxaban | 81 | $88,444 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 84 | $74,603 |
| CreonLipase/Protease/Amylase | 47 | $63,122 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 83 | $58,008 |
| OzempicSemaglutide | 27 | $43,681 |
| Repatha SureclickEvolocumab | 26 | $38,309 |
| KerendiaFinerenone | 26 | $29,460 |
| RybelsusSemaglutide | 15 | $26,045 |
| GemtesaVibegron | 15 | $19,173 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| MerckJanuvia, Janumet Xr | $498 | $340,607288 claims |
| Boehringer IngelheimJardiance | $349 | $245,901180 claims |
| AbbVieLinzess, Creon | $2,545 | $239,398207 claims |
| AstraZenecaFarxiga, Breztri Aerosphere, Symbicort | $3,507 | $225,163220 claims |
| Lilly USA, LLCTrulicity | $724 | $157,132128 claims |
| PfizerEliquis | $1,531 | $116,081104 claims |
| Johnson & JohnsonXarelto | $980 | $88,44481 claims |
| GSKTrelegy Ellipta, Anoro Ellipta | $976 | $81,12695 claims |
| Novo NordiskOzempic, Rybelsus | $1,229 | $69,72642 claims |
| BayerKerendia | $1,119 | $29,46026 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $403 | $19,17315 claims |
| Astellas Pharma US IncMyrbetriq | $687 | $14,39622 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 421 medical providers in Massachusetts.
Other medical in Lawrence
- Eileen CheeverLeominster$389K
- Michelle BaytarianJamaica Plain$17K
- Julia FioreAgawam$16K
- Jennifer LevesqueFall River$15K
- Ashley HoffmanWestfield$13K
- Theresa FukudaBoston$13K
- Christina MessingerPlymouth$11K
- Lauren CarraSpringfield$9K
- Raul AliceaSpringfield$9K
- Robert HarrisMilton$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.